<http://purl.obolibrary.org/obo/OBI_0002446> <http://purl.obolibrary.org/obo/IAO_0000117> "Dan Berrios" <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0002446> <http://purl.obolibrary.org/obo/IAO_0000119> "OBI:0001441" <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0002446> <http://www.w3.org/2000/01/rdf-schema#label> "proteomic profiling design" <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0002446> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#Class> <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0002446> <http://purl.obolibrary.org/obo/IAO_0000115> "A study design in which proteins in a sample are detected, quantified or otherwise analysed." <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0002446> <http://purl.obolibrary.org/obo/IAO_0000111> "proteomic profiling design" <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0002446> <http://purl.obolibrary.org/obo/IAO_0000114> <http://purl.obolibrary.org/obo/IAO_0000120> <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0002446> <http://www.w3.org/2000/01/rdf-schema#subClassOf> <http://purl.obolibrary.org/obo/OBI_0500000> <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0001425> <http://purl.obolibrary.org/obo/IAO_0000119> "MO_933 binding_site_identification_design"@en <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0001425> <http://www.w3.org/2000/01/rdf-schema#label> "protein binding site identification design"@en <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0001425> <http://purl.obolibrary.org/obo/IAO_0000115> "A study design that investigates protein binding sites on nucleic acids."@en <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0001425> <http://purl.obolibrary.org/obo/IAO_0000114> <http://purl.obolibrary.org/obo/IAO_0000120> <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0001425> <http://www.w3.org/2000/01/rdf-schema#subClassOf> <http://purl.obolibrary.org/obo/OBI_0500000> <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0001425> <http://www.w3.org/2002/07/owl#equivalentClass> _:B4f5a3082c54aee15c8a44ec394c4e518 <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0001425> <http://purl.obolibrary.org/obo/IAO_0000111> "protein binding site identification design"@en <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0001425> <http://purl.obolibrary.org/obo/IAO_0000117> "Person: Chris Stoeckert, Jie Zheng"@en <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0001425> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#Class> <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0001454> <http://purl.obolibrary.org/obo/IAO_0000119> "MO_807 pathogenicity_design"@en <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0001454> <http://www.w3.org/2000/01/rdf-schema#subClassOf> _:B0af78990e3c2f6223e71d70224f6af3f <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0001454> <http://purl.obolibrary.org/obo/IAO_0000111> "pathogenicity design"@en <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0001454> <http://purl.obolibrary.org/obo/IAO_0000114> <http://purl.obolibrary.org/obo/IAO_0000120> <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0001454> <http://www.w3.org/2000/01/rdf-schema#subClassOf> <http://purl.obolibrary.org/obo/OBI_0500000> <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0001454> <http://www.w3.org/2000/01/rdf-schema#label> "pathogenicity design"@en <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0001454> <http://purl.obolibrary.org/obo/IAO_0000117> "Person: Chris Stoeckert, Jie Zheng" <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0001454> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#Class> <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0001454> <http://purl.obolibrary.org/obo/IAO_0000115> "A study design in which an infective agent such as a bacterium, virus, protozoan, fungus etc. infects a host organism(s) and the infective agent is assayed."@en <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0001358> <http://purl.obolibrary.org/obo/IAO_0000115> "A study design in which a modification of the transcriptome, proteome (not genome) is made, for example RNAi, antibody targeting."@en <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0001358> <http://purl.obolibrary.org/obo/IAO_0000111> "post-transcriptional modification design"@en <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0001358> <http://purl.obolibrary.org/obo/IAO_0000114> <http://purl.obolibrary.org/obo/IAO_0000120> <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0001358> <http://purl.obolibrary.org/obo/IAO_0000119> "MO_392 cellular_modification_design"@en <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0001358> <http://www.w3.org/2000/01/rdf-schema#subClassOf> _:B2b10d03f59662c0e958ea08dda65a9b2 <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0001358> <http://www.w3.org/2000/01/rdf-schema#label> "post-transcriptional modification design"@en <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0001358> <http://www.w3.org/2000/01/rdf-schema#subClassOf> _:B0aaba884e836756aa01b84af24e8320a <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0001358> <http://www.w3.org/2000/01/rdf-schema#comment> "post transcription modification design?\nor more clear RNAi design / antibody targeting design?\nneed to check the use cases"@en <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0001358> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#Class> <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0001358> <http://www.w3.org/2000/01/rdf-schema#subClassOf> <http://purl.obolibrary.org/obo/OBI_0000115> <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0001358> <http://purl.obolibrary.org/obo/IAO_0000117> "Person: Chris Stoeckert, Jie Zheng" <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0001401> <http://purl.obolibrary.org/obo/IAO_0000119> "MO_934 optimization_design"@en <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0001401> <http://purl.obolibrary.org/obo/IAO_0000115> "A study design where different protocols or protocol parameters are compared aims to find an optimized protocol"@en <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0001401> <http://purl.obolibrary.org/obo/IAO_0000114> <http://purl.obolibrary.org/obo/IAO_0000120> <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0001401> <http://www.w3.org/2000/01/rdf-schema#subClassOf> <http://purl.obolibrary.org/obo/OBI_0500000> <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0001401> <http://www.w3.org/2000/01/rdf-schema#label> "protocol optimization design"@en <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0001401> <http://purl.obolibrary.org/obo/IAO_0000111> "protocol optimization design"@en <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0001401> <http://www.w3.org/2000/01/rdf-schema#subClassOf> _:B62d734fe1ffe0ada7db4c56dd0f33484 <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0001401> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#Class> <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0001401> <http://purl.obolibrary.org/obo/IAO_0000117> "Person: Chris Stoeckert, Jie Zheng" <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0500006> <http://www.w3.org/2000/01/rdf-schema#label> "parallel group design"@en <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0500006> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#Class> <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0500006> <http://purl.obolibrary.org/obo/IAO_0000112> "PMID: 17408389-Purpose: Proliferative vitreoretinopathy (PVR) is the most important reason for blindness following retinal detachment. Presently, vitreous tamponades such as gas or silicone oil cannot contact the lower part of the retina. A heavier-than-water tamponade displaces the inflammatory and PVR-stimulating environment from the inferior area of the retina. The Heavy Silicone Oil versus Standard Silicone Oil Study (HSO Study) is designed to answer the question of whether a heavier-than-water tamponade improves the prognosis of eyes with PVR of the lower retina. Methods: The HSO Study is a multicentre, randomized, prospective controlled clinical trial comparing two endotamponades within a two-arm parallel group design. Patients with inferiorly and posteriorly located PVR are randomized to either heavy silicone oil or standard silicone oil as a tamponading agent. Three hundred and fifty consecutive patients are recruited per group. After intraoperative re-attachment, patients are randomized to either standard silicone oil (1000 cSt or 5000 cSt) or Densiron((R)) as a tamponading agent. The main endpoint criteria are complete retinal attachment at 12 months and change of visual acuity (VA) 12 months postoperatively compared with the preoperative VA. Secondary endpoints include complete retinal attachment before endotamponade removal, quality of life analysis and the number of retina affecting re-operation within 1 year of follow-up. Results: The design and early recruitment phase of the study are described. Conclusions: The results of this study will uncover whether or not heavy silicone oil improves the prognosis of eyes with PVR."@en <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0500006> <http://purl.obolibrary.org/obo/IAO_0000114> <http://purl.obolibrary.org/obo/IAO_0000125> <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0500006> <http://purl.obolibrary.org/obo/IAO_0000119> "http://www.holah.karoo.net/experimentaldesigns.htm"@en <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0500006> <http://www.w3.org/2000/01/rdf-schema#subClassOf> <http://purl.obolibrary.org/obo/OBI_0500000> <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0500006> <http://purl.obolibrary.org/obo/IAO_0000117> "Philippe Rocca-Serra"@en <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0500006> <http://purl.obolibrary.org/obo/IAO_0000115> "A parallel group design or independent measure design is a study design which uses unique experimental unit each experimental group, in other word no two individuals are shared between experimental groups, hence also known as parallel group design. Subjects of a treatment group receive a unique combination of independent variable values making up a treatment"@en <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0500006> <http://purl.obolibrary.org/obo/IAO_0000118> "independent measure design"@en <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0500006> <http://purl.obolibrary.org/obo/IAO_0000111> "parallel group design"@en <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0001441> <http://purl.obolibrary.org/obo/IAO_0000233> "https://github.com/obi-ontology/obi/issues/854" <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0001441> <http://purl.obolibrary.org/obo/IAO_0000114> <http://purl.obolibrary.org/obo/IAO_0000120> <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0001441> <http://purl.obolibrary.org/obo/IAO_0000111> "proteomic profiling by array design"@en <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0001441> <http://www.w3.org/2000/01/rdf-schema#subClassOf> <http://purl.obolibrary.org/obo/OBI_0500000> <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0001441> <http://www.w3.org/2000/01/rdf-schema#subClassOf> _:B9e4d1a1cf87de325f5974427e022223d <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0001441> <http://purl.obolibrary.org/obo/IAO_0000119> "Group: ArrayExpress production team"@en <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0001441> <http://purl.obolibrary.org/obo/IAO_0000117> "Person: Chris Stoeckert, Jie Zheng, Dan Berrios" <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0001441> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#Class> <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0001441> <http://www.w3.org/2000/01/rdf-schema#label> "proteomic profiling by array design"@en <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0001441> <http://purl.obolibrary.org/obo/IAO_0000115> "A study design in which proteins in a sample are detected, quantified or otherwise analysed, through an array-based technology."@en <http://purl.obolibrary.org/obo/obi.owl> .
<https://w3id.org/GDPRtEXT#PrivacyByDesign> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#Class> <https://w3id.org/GDPRtEXT> .
<https://w3id.org/GDPRtEXT#PrivacyByDesign> <http://www.w3.org/2000/01/rdf-schema#isDefinedBy> <https://w3id.org/GDPRtEXT/gdpr#article25> <https://w3id.org/GDPRtEXT> .
<https://w3id.org/GDPRtEXT#PrivacyByDesign> <http://www.w3.org/2000/01/rdf-schema#label> "Privacy by Design" <https://w3id.org/GDPRtEXT> .
<https://w3id.org/GDPRtEXT#PrivacyByDesign> <http://www.w3.org/2000/01/rdf-schema#subClassOf> <https://w3id.org/GDPRtEXT#ControllerObligation> <https://w3id.org/GDPRtEXT> .
<https://w3id.org/GDPRtEXT#PrivacyByDesign> <http://www.w3.org/2000/01/rdf-schema#isDefinedBy> <https://w3id.org/GDPRtEXT/gdpr#recital78> <https://w3id.org/GDPRtEXT> .
<https://w3id.org/GDPRtEXT#PrivacyByDesign> <http://www.w3.org/2000/01/rdf-schema#comment> "Privacy by Design is the approach of taking privacy into consideration throughout the whole planning and execution processes."@en <https://w3id.org/GDPRtEXT> .
<https://w3id.org/cdc#DesignDS> <http://www.w3.org/2002/07/owl#disjointWith> <https://w3id.org/cdc#OwnerRequirementsDS> <https://w3id.org/cdc> .
<https://w3id.org/cdc#DesignDS> <http://www.w3.org/2000/01/rdf-schema#label> "design dataset"@en <https://w3id.org/cdc> .
<https://w3id.org/cdc#DesignDS> <http://www.w3.org/2000/01/rdf-schema#isDefinedBy> <https://w3id.org/cdc> <https://w3id.org/cdc> .
<https://w3id.org/cdc#DesignDS> <http://www.w3.org/2000/01/rdf-schema#comment> "In contrast to an as-built dataset (cdc:AsBuiltDS), this type of construction dataset describes a future situation that is the outcome of some type of design process. Use its subclasses to be more specific about the type of design/planning."@en <https://w3id.org/cdc> .
<https://w3id.org/cdc#DesignDS> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#Class> <https://w3id.org/cdc> .
<https://w3id.org/cdc#DesignDS> <http://www.w3.org/2000/01/rdf-schema#subClassOf> <http://www.w3.org/ns/dcat#Dataset> <https://w3id.org/cdc> .
